Data / Form D filings / Pierrepont Therapeutics, Inc.
Pierrepont Therapeutics, Inc.: Form D filings
Pierrepont Therapeutics, Inc., a pharmaceuticals company in Brooklyn, NY, filed 2 Form D notices with the SEC between 2024 and 2026. The latest, on September 22, 2026, reports $2.4 million sold of a $5.9 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- DOWNSTATE TECHNOLOGY CENTER, SUITE 327A 760 PARKSIDE AVENUE, Brooklyn, NY, 11203
- Phone
- (212) 430-1740
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2019360
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Amendment | $5,859,876 | $2,409,876 | $3,450,000 | 2 | Apr 2, 2024 | sec.gov |
| Apr 15, 2024 | New notice | $5,859,876 | $2,109,876 | $3,750,000 | 2 | Apr 2, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter H. Barber | Executive Officer, Director | |
| Daniel DiPietro | Director | |
| Matthew Wyckoff | Director |
Every Form D from the week of Sep 21, 2026 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pierrepont Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.